198474-61-2

Basic information

• Product Name: N-tert-Butyloxycarbonyl-S-(4-methylbenzyl)-D-penicillamine dicyclohexylamine
• Synonyms: N-ALPHA-T-BOC-S-4-METHYLBENZYL-L-PENICILLAMINE DICYCLOHEXAMMONIUM SALT;N-ALPHA-T-BUTOXYCARBONYL-S-P-METHYLBENZYL-L-PENICILLAMINE;BOC-S-4-METHYLBENZYL-L-PENICILLAMINE;BOC(S-4-METHYLBENZYL)-L-PENICILLAMINE DICYCLOHEXYLAMINE SALT;BOC-S-4-METHYLBENZYL-L-PENICILLAMINE DICYCLOHEXYLAMMONIUM SALT;BOC-L-PENICILLAMINE(S-P-METHYLBENZYL) DICYCLOHEXYLAMINE SALT;BOC-PEN(MBZL)-OH DCHA;BOC-PEN(PMEBZL)-OH
• CAS NO: 198474-61-2
• Molecular Formula: C30H50N2O4S
• Molecular Weight: 534.79
• Product Categories: Amino Acids;Unusual Amino Acids;Boc-Amino acid series
• Mol File: 198474-61-2.mol

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: N-tert-Butyloxycarbonyl-S-(4-methylbenzyl)-D-penicillamine dicyclohexylamine(CAS DataBase Reference)
• NIST Chemistry Reference: N-tert-Butyloxycarbonyl-S-(4-methylbenzyl)-D-penicillamine dicyclohexylamine(198474-61-2)
• EPA Substance Registry System: N-tert-Butyloxycarbonyl-S-(4-methylbenzyl)-D-penicillamine dicyclohexylamine(198474-61-2)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 198474-61-2(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
N-tert-Butyloxycarbonyl-S-(4-methylbenzyl)-D-penicillamine dicyclohexylamine is used as a synthetic intermediate for the production of various pharmaceuticals and medical treatments. Its role in synthesis processes is crucial for creating new drug molecules that address a range of health conditions.
Used in Drug Synthesis:
N-tert-Butyloxycarbonyl-S-(4-methylbenzyl)-D-penicillamine dicyclohexylamine acts as a precursor in the synthesis of drugs, where its unique structure and functional groups facilitate the formation of the desired pharmaceutical agents. The N-Boc group and dicyclohexylamine provide the necessary protection and stabilization, ensuring the successful synthesis of the target compounds.
Used in Medical Treatments:
N-tert-Butyloxycarbonyl-S-(4-methylbenzyl)-D-penicillamine dicyclohexylamine is utilized in the development of medical treatments that require the creation of novel therapeutic agents. Its presence in the synthesis process allows for the production of drugs that can be tailored to treat specific diseases or conditions more effectively.